Compare SIBN & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SIBN | AIO |
|---|---|---|
| Founded | 2008 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 671.7M | 777.8M |
| IPO Year | 2018 | N/A |
| Metric | SIBN | AIO |
|---|---|---|
| Price | $13.12 | $21.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $24.13 | N/A |
| AVG Volume (30 Days) | ★ 512.4K | 82.9K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.05% |
| EPS Growth | ★ 41.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,301,000.00 | N/A |
| Revenue This Year | $16.89 | N/A |
| Revenue Next Year | $14.95 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.53 | N/A |
| 52 Week Low | $12.50 | $16.18 |
| 52 Week High | $21.89 | $25.47 |
| Indicator | SIBN | AIO |
|---|---|---|
| Relative Strength Index (RSI) | 32.80 | 35.98 |
| Support Level | N/A | $21.46 |
| Resistance Level | $19.35 | $23.59 |
| Average True Range (ATR) | 0.80 | 0.37 |
| MACD | -0.11 | -0.12 |
| Stochastic Oscillator | 3.09 | 7.04 |
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.